Two genetic pathways for age-related macular degeneration

被引:28
作者
DeWan, Andrew [1 ]
Bracken, Michael B. [1 ]
Hoh, Josephine [1 ]
机构
[1] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.gde.2007.04.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The discovery of strong associations of the His402 variant of complement factor H (CFH) and the change in the promoter region of HtrA serine peptidase 1 (HTRA1) with age-related macular degeneration (AMD) have altered our conception of the pathophysiology of this disease. The complement system has been placed at the center of a flurry of research interest, and a similar growth in attention to the serine proteases is not far behind. The specific role of these variants in causing AMD is unknown, but they will undoubtedly lead to a deeper understanding of the biological mechanisms and will point to new avenues for pharmacologic management. Furthermore, these variants will enable clinicians and investigators to identify people at high risk for this condition, thereby establishing the preconditions for preventing the disease.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 46 条
[31]   FORMATION OF THE INITIAL C-3 CONVERTASE OF THE ALTERNATIVE COMPLEMENT PATHWAY - ACQUISITION OF C3B-LIKE ACTIVITIES BY SPONTANEOUS HYDROLYSIS OF THE PUTATIVE THIOESTER IN NATIVE C-3 [J].
PANGBURN, MK ;
SCHREIBER, RD ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :856-867
[32]   Macular degeneration: recent advances and therapeutic opportunities [J].
Rattner, Amir ;
Nathans, Jeremy .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (11) :860-872
[33]   HUMAN MHC CLASS-III (BF, C2, C-4) GENES AND GLO - THEIR ASSOCIATION WITH OTHER HLA ANTIGENS AND EXTENDED HAPLOTYPES IN THE SPANISH POPULATION [J].
REGUEIRO, JR ;
ARNAIZVILLENA, A .
TISSUE ANTIGENS, 1988, 31 (01) :14-25
[34]   Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk [J].
Rivera, A ;
Fisher, SA ;
Fritsche, LG ;
Keilhauer, CN ;
Lichtner, P ;
Meitinger, T ;
Weber, BHF .
HUMAN MOLECULAR GENETICS, 2005, 14 (21) :3227-3236
[35]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[36]   High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration [J].
Sandberg, MA ;
Weiner, A ;
Miller, S ;
Gaudio, AR .
OPHTHALMOLOGY, 1998, 105 (03) :441-447
[37]   A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration [J].
Schaumberg, Debra A. ;
Christen, William G. ;
Kozlowski, Piotr ;
Miller, David T. ;
Ridker, Paul M. ;
Zee, Robert Y. L. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (06) :2336-2340
[38]   C5a anaphylatoxin as a product of complement activation up-regulates the complement inhibitory factor H in rat Kupffer cells [J].
Schlaf, G ;
Nitzki, F ;
Heine, I ;
Hardeland, R ;
Schieferdecker, HL ;
Götze, O .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) :3257-3266
[39]   Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration [J].
Schmidt, S ;
Hauser, MA ;
Scott, WK ;
Postel, EA ;
Agarwal, A ;
Gallins, P ;
Wong, F ;
Chen, YS ;
Spencer, K ;
Schnetz-Boutaud, N ;
Haines, JL ;
Pericak-Vance, MA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 78 (05) :852-864
[40]   Progression of age-related macular degeneration - Prospective assessment of c-reactive protein, interleukin 6, and other cardiovascular biomarkers [J].
Seddon, JM ;
George, S ;
Rosner, B ;
Rifai, N .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (06) :774-782